Peptides isolated from random peptide libraries on phage elicit a neutralizing anti-HIV-1 response: Analysis of immunological mimicry

Immunology

Volumn 89, Issue 4, 1996, Pages 579-586

  Lundin, K ^a,b   Samuelsson, A ^a,b   Jansson, M ^b   Hinkula, J ^b   Wahren, B ^b   Wigzell, H ^b   Persson, M A A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029856429     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-772.x     Document Type: Article

References (36)

1. PROFY A.T., SALINAS P.A., ECKER L.I., DUNLOP N.M., NARA P.L. & PUTNEY S.D. (1990) Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. J Immunol 144, 4641.
2. STEIMER K.S., SCANDELL C.J., SKILES P.V. & HAIGWOOD N.L. (1991) Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. Science 254, 105.
3. BROLIDEN, P.-A., VON GEGERFELT A., CLAPHAM P. et al. (1992) Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci USA 89, 461.
4. PALKER T.J., CLARK M.E., LANGLOIS A.J. et al. (1988) Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci USA 85, 1932.
5. ÅKERBLOM L., HINKULA J., BROLIDEN, P.-A. et al. (1990) Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. AIDS 4, 953.
6. HO D., MCKEATING J., LI X. et al. (1991) Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J Virol 65, 489.
7. TILLEY S., HONNEN W.J., RACHO M., HILGARTNER M. & PINTER A. (1991) A human monoclonal antibody against the CD4 binding site of HIV-1 gp120 exhibits potent, broadly neutralizing activity. Res Virol 142, 247.
8. MOORE J.P. CAO Y.Z., CONLEY A.J. et al. (1994) Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid phase peptide binding assays. J AIDS 7, 332.
9. SCOTT, J.K. & SMITH G.P. (1990) Searching for peptide ligands with an epitope library. Science 249, 386.
10. DEVLIN J.J., PANGANIBAN L.C. & DEVLIN P.E. (1990) Random peptide libraries: A source of specific protein binding molecules. Science 249, 404.
11. CWIRLA S.E., PETERS E.A., BARRETT R.W. & DOWER W.J. (1990) Peptides on phage: A vast library of peptides for identifying ligands. Proc Natl Acad Sci USA 87, 6378.
12. KELLER P.M., ARNOLD B.A., SHAW A.R. et al. (1993) Identification of HIV vaccine candidate peptides by screening random phage epitope libraries. Virology 193, 709.
13. BLOND-ELGUINDI S., CWIRLA S.E., DOWER W.J. et al. (1993) Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell 75, 717.
14. PARMLEY, S.F. & SMITH G.P. (1988) Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 73, 305.
15. ZACHER III A.N., STOCK C.A., GOLDEN II J.W. & SMITH G.P. (1980) A new filamentous phage cloning vector: fd-tet. Gene 9, 127.
16. SAMBROOK J., FRITSCH E.F. & MANIATIS T. (1989) In: Molecular cloning, A laboratory manual (ed. C. Nolan) pp. A1-A2. Cold Spring Harbor laboratory Press, Cold Spring Harbor, NY, USA.
17. BARBAS III C.F., KANG A.S., LERNER, R.A. & BENKOVIC S.J. (1991) Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc Natl Acad Sci USA 88, 7978.
18. BROLIDEN P.A., MAKITALO B., ÅKERBLOM L. et al. (1991) Identification of amino acids in the V3 region of gp120 ctitical for virus neutralization by human HIV-1-specific antibodies. Immunology 73, 371.
19. HINKULA J., ROSEN J., SUNDQVIST, V.-A., Stigbrand T. & WAHREN B. (1990) Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Mol Immunol 27, 395.
20. STÁHL S., HULTMAN T., MOKS T. & UHLÉN M. (1988) Solid phase DNA sequencing using the biotin-avidin system. Nucleic Acids Res 16, 3025.
21. SANGER F., NICKLEN S. & COULSON A.R. (1977) DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74, 5463.
22. MERRIFIELD R.B. (1963) Solid phase peptide synthesis. The synthesis of a tetrapeptide. J Am Chem Soc 85, 2149.
23. MEYERHOFER J., WAKI M., HEIMER E.P., LAMBROS T.J., MAKOFSKE R.C. & CHANG, C.-D. (1976) Solid phase synthesis without repetitive acidolysis: Preparation of leucyl-alanyl-glycyl-valin using 9-fluorenyl-methyl oxycarbonyl amino acids. Int J Peptide Protein Res 13, 35.
24. KANG A.S., BARBAS III C.F., JANDA K.D., BENKOVIC S.J. & LERNER R.A. (1991) Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc Natl Acad Sci USA 88, 4363.
25. PERSSON M.A.A., CAOTHIEN R.H. & BURTON D.R. (1991) Generation of diverse high affinity human monoclonal antibodies by repertoire cloning. Proc Natl Acad Sci USA 88, 2432.
26. SUNDQVIST V.A., ALBERT J., OHLSSON E., HINKULA J., FENYÖ. E.-M. & WAHREN B. (1989) Human immunodeficiency virus type 1 p. 24 production and antigen variation in tissue culture of isolates with various growth characteristics. J Med Virol 29, 170.
27. MATHIESEN T., SÖNNERBORG A. & WAHREN B. (1989) Detection of antibodies against myelin basic protein and increased levels of HIV-IgG antibodies and HIV antigen after solubilization of immune complexes in sera and CSF of HIV infected patients. Virol Immunol 2, 1.
28. NARA P.L., HATCH W.C., DUNLOP N.M. et al. (1987) Simple, rapid quantitative syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses 3, 283.
29. MAKOWSKI L. (1993) Structural constraints on the display of foreign peptides on filamentous bacteriophages. Gene 128, 5.
30. GHIARA J.B., STURA E.A., STANFIELD R.L., PROFY A.T. & WILSON I.A. (1994) Crystal structure of the principal neutralization site of HIV-1. Science 264, 82.
31. ZHONG G., SMITH G.P., BERRY J. & BRUNHAM R.C. (1994) Conformational mimicry of a chlamydial neutralization epiotpe on filamentous phage. J Biol Chem 269, 24183.
32. VANCOTT T.C., BETHKE F.R., POLONIS V.R. et al. (1994) Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1. J Immunol 153, 449.
33. MATHIESEN T. BROLIDEN P.A., ROSEN J. & WAHREN B. (1989) Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides. Immunology 67, 453.
34. DE LA CRUZ V.F. LAL A.A. & MCCUTCHAN T.F. (1988) Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J Biol Chem 263, 4318.
35. ARNON R. (1991) Synthetic peptides as the basis for vaccine design. Mol Immunol 28, 215.
36. STEWARD M.W., STANLEY C.M. & OBEID O.E. (1995) A mimotope from a solid phase peptide library induces a measles virus-neutralizing and protective antibody response. J Virol 69, 7668.